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Abstract
In mammals, the Y chromosome is a dominant male determinant, causing the bipotential gonad to develop as a testis.
Recently, cases of familial and spontaneous 46,XY disorders of sex development (DSD) have been attributed to mutations in
the human gene encoding mitogen-activated protein kinase kinase kinase 1, MAP3K1, a component of the mitogen-
activated protein kinase (MAPK) signal transduction pathway. In individuals harbouring heterozygous mutations in MAP3K1,
dysregulation of MAPK signalling was observed in lymphoblastoid cell lines, suggesting a causal role for these mutations in
disrupting XY sexual development. Mice lacking the cognate gene, Map3k1, are viable and exhibit the eyes open at birth
(EOB) phenotype on a mixed genetic background, but on the C57BL/6J genetic background most mice die at around 14.5
dpc due to a failure of erythropoiesis in the fetal liver. However, no systematic examination of sexual development in
Map3k1-deficient mice has been described, an omission that is especially relevant in the case of C57BL/6J, a genetic
background that is sensitized to disruptions to testis determination. Here, we report that on a mixed genetic background
mice lacking Map3k1 are fertile and exhibit no overt abnormalities of testis development. On C57BL/6J, significant non-
viability is observed with very few animals surviving to adulthood. However, an examination of development in Map3k1-
deficient XY embryos on this genetic background revealed no significant defects in testis determination, although minor
abnormalities were observed, including an increase in gonadal length. Based on these observations, we conclude that
MAP3K1 is not required for mouse testis determination. We discuss the significance of these data for the functional
interpretation of sex-reversing MAP3K1 mutations in humans.
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Introduction
Disorders of sex development (DSD) comprise a large number of
cases in which development of chromosomal, gonadal or anatom-
ical sex is atypical [1]. 46,XY gonadal dysgenesis (GD) is
characterised by abnormal testicular determination. Individuals
with 46,XYGDmay be completely masculinised, feminised or have
ambiguous genitalia. In cases of pure or complete gonadal
dysgenesis (CGD), the testes are absent and bilateral streak gonads
are observed, along with concomitant female internal and external
genitalia. Molecular genetic analyses of individuals exhibiting
46,XYGD and CGD have played a crucial role in the identification
of human testis-determining genes: SRY [2], SOX9 [3,4], WT1 [5]
and SF1 [6] were all established as sex determining in humans on
the basis of molecular lesions in individuals with 46,XY GD.
However, it has been estimated that approximately 60-70% of all
cases of XY GD remain unexplained at the molecular level [7].
Attempts to identify these missing human testis determining
genes have recently focused on the study of familial cases of
46,XY DSD unlinked to known genes [8,9]. In one such family,
46,XY GD was transmitted as an autosomal dominant trait with
highly variable expressivity, ranging from CGD to partial GD
associated with normal female genitalia, sexual ambiguity or mild
hypospadias in affected males [10]. Linkage analysis in this family
placed the mutated locus on the pericentric region of chromo-
some 5 [11]. Recently, we attributed the cause of 46,XY GD in
this, and a second family [12], to mutations in the gene encoding
the signal transduction molecule, MAP3K1 [13]. Two sporadic
cases of 46,XY GD were also reported to harbour MAP3K1
mutations. MAP3K1 (also known as MEK kinase 1 (MEKK1))
encodes a MAPK kinase kinase that acts as part of a
phosphorelay triad to phosphorylate the MAPKs JNK, ERK
and p38, with a strong preference for the JNK pathway
[14,15,16]. The MAPK pathway acts to integrate diverse signals
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to regulate a variety of cellular functions such as cell cycle
progression, cell adherence, motility and metabolism and thereby
influence a number of developmental processes. In particular,
mammalian sex determination is regulated by growth factors such
as insulin-like growth factors [17], fibroblast growth factors
[18,19,20], prostaglandins [21,22] and platelet-derived growth
factors [23]. MAP3K1 might act to regulate or integrate such
signals during testis development [24].
Analysis of MAPK signalling activity in lymphoblastoid cell
lines derived from individuals with sex-reversing MAP3K1
mutations revealed enhanced phosphorylation of the MAPKs
p38 and ERK after serum starvation followed by re-feeding [13].
Moreover, RHOA, a known positive regulator of MAP3K1
kinase activity, exhibited increased binding to protein complexes
containing mutant MAP3K1. These data raise the possibility
that, at least in the lymphoblastoid cell line context, mutant
versions of MAP3K1 behave like gain-of-function alleles, enhanc-
ing functionality of the encoded protein. This possibility is also
consistent with the absence of any truncating, loss-of-function,
mutations in the 46,XY GD patient cohorts examined. However,
direct targets of MAP3K1 were not assayed. Moreover, crosstalk
between the ERK and JNK/p38 pathways is reported to regulate
apoptosis in some contexts, indicating that the distinct MAPK
pathways are not insulated from each other [25]. Thus,
disruption to one element of the MAPK signalling network may
conceivably cause consequential activation of other components.
Along with the fact that all these functional studies were
performed in heterologous lymphoblastoid cell lines, these
observations indicate that no definitive explanation yet exists
for how these MAP3K1 mutations disrupt human testis determi-
nation.
We have recently established a role for another MAP3K in
mouse sex determination [26]. A forward genetic screen identified
the boygirl (byg) mutation, which in homozygous embryos on the
C57BL/6J background causes XY gonadal sex reversal. Positional
cloning identified a point mutation in Map3k4, resulting in a
premature stop codon and, thus, a null allele. Analysis of gonad
development in XY byg/byg embryos revealed failure to execute the
testis-determining programme due to delayed and greatly reduced
levels of Sry expression. These data, and those implicating MAP3K1
in human testis development, suggest a conserved role for MAPK
signalling in mammalian sex determination. However, it is unclear
whether sex determination in the mouse utilises MAP3K4
exclusively, or whether a role exists for MAP3K1 too. Mice lacking
Map3k1 have been described and, along with disruption to MAPK
signalling, these exhibit defects in embryonic eyelid closure; but no
defects in sexual development have been reported on a mixed
genetic background, although no systematic study has been
described [15,16,27,28]. However, on the C57BL/6J background,
one that is especially sensitive to disruptions to the testis
determination pathway, Map3k1-deficient mice are non-viable due
to defects in foetal erythropoiesis [29]. Thus, a careful examination
of XY gonad development on this background is required to address
the role of MAP3K1 in mouse testis determination and allow
comparison with its role in humans. Here we show that no overt
abnormalities in testis determination are observed in Map3k1-
deficient XY embryos on C57BL/6J, although minor defects are
apparent. Moreover, no additional abnormalities are observed in
mice lacking Map3k1 and a single copy of Map3k4, suggesting that
no genetic interaction occurs between these loci during sex
determination. We conclude, therefore, that MAP3K1 is not
required for mouse testis determination.
Materials and Methods
Mouse mutants utilized and genotyping
The Map3k1DKD allele generates a MAP3K1-b-galactosidase
fusion protein containing the first 1188 amino acids of MAP3K1,
but entirely lacking the kinase domain required for its function
[16]. Map3k1DKD mice were maintained on two distinct genetic
backgrounds: C57BL/6J, by out-crossing, and a mixed C57BL/
6J-C3H/HeH background by continual intercrossing. Mice and
embryos were genotyped using a novel three-primer PCR assay in
which mutant (216 bp) and wild-type (475 bp) products were
amplified using primers: 59-GCGATGTCGCGTCTCAGG-39,
59-GGCCTTTCAGCCACTCAGC-39 and 59-AAAGCGCCAT-
TCGCCATT-39. Map3k4tm1Flv/+ mice [30] were maintained on
C57BL/6J and genotyped as previously described [26]. Embryos
were sexed by a PCR assay that simultaneously amplifies the
Ube1y1 and Ube1x genes as previously described [31]. All mice
were bred under standard conditions of care and used under
licensed approval from the UK Home Office (PPL 30/2381: Dr A
Greenfield). This investigation conforms with the Guide for the Care
and Use of Laboratory Animals published by the US National Institutes
of Health (NIH Publication No. 85–23, revised 1996).
Generation of mutant embryos and expression analyses
Noon on the day of the copulatory plug was counted as 0.5 dpc.
Embryos were staged accurately based on the number of tail somites
or limb and gonad morphology. Wholemount in situ hybridization
(WMISH) analysis of embryonic tissues was performed as previously
described [32,33]. Probes for Sox9 [34], Oct4 and 3ßHSD [35], Stra8
and Wnt4 [26] have been previously described.
Detection of the Map3k1DKD reporter was performed using a
protocol based on one previously described [36]. Embryos were
dissected in PBS to expose the developing reproductive organs/
tracts, fixed on ice (1% PFA, 0.2% glutaraldehyde, 2 mM MgCl2,
5 mM EGTA, 0.02% NP-40 in PBS) and then washed in PBS/
0.02% NP-40. Staining was carried out in the dark, at room
temperature for 16 hrs or until blue colour fully developed in X-
gal stain (PBS containing 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6,
2 mM MgCl2, 0.01% deoxycholate, 0.02% NP-40, 1 mg/ml X-
Gal). Samples were post-fixed in 4% PFA/PBS.
Immunohistochemistry and Western blotting
A commercially available antibody was used to detect AMH
(MIS (C-20):sc-6886, Santa Cruz). Immunostaining was performed
on wax sections and imaged using a Leica TCS SP5 confocal as
previously described [26,37]. Antibodies against p38 (#9212, Cell
Signaling), phospho-p38 (pp38) (#4631, Cell Signaling) and ß-actin (A
2066, Sigma) were used for Western blotting. Gonads from control
and mutant 12.5 dpc embryos were lysed in Tris-buffered saline
(pH8) containing 1% NP40 and a cocktail of protease and
phosphatase inhibitors (cOmplete mini 04 693 124 001 Roche,
PhosSTOP 04 906 837 001 Roche and sodium orthovanadate
P078S New England BioLabs). 2 mg from each protein sample was
loaded on NuPAGE 4–12% Bis/Tris gel (Invitrogen), blotted onto
nitrocellulose membrane (Invitrogen) and blocked in Tris-buffered
saline containing 0.1% tween-20 and 5% dry skimmed milk.
Antibodies were diluted in blocking solution at 1:1000 (anti-p38 and
-pp38), 1:2000 (anti-actin) and 1:3000 (anti-rabbit-HRP). Incuba-
tion with primary antibodies proceeded overnight at 4uC and with
secondary antibody for 1 hour at room temperature. ECL or ECL
Plus systems (GE Healthcare) were used for detection.
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Results
Map3k1 is expressed in male and female gonads at the
sex determining stage of gonadogenesis
We first analysed expression of Map3k1 in the developing
gonads by exploiting a lacZ reporter engineered into the targeted
Map3k1DKD allele [16]. Examination of ß-galactosidase activity in
the gonads of Map3k1DKD/+ embryos revealed weak lacZ reporter
activity in both the XX and XY gonads at 11.0 dpc in the gonad,
Wolffian duct and mesonephric tubules, but no staining was
detected prior to this at 10.5dpc (data not shown). At 11.5 dpc, the
sex-determining stage of gonad development, prominent expres-
sion was observed throughout the gonad with the highest levels in
the coelomic region at the periphery of the gonad in both XY and
XX gonads (Fig. 1A–C). By 13.5 dpc signal was detected in the
coelomic region of the testis and in the developing reproductive
tracts and mesonephric tubules (Fig. 1D–F). We have previously
described WMISH analysis with aMap3k1 probe and the profile of
expression obtained was identical with that of the lacZ reporter at
the sex determining stage (11.5 dpc). However, in contrast to the
reporter profile, in situ analysis revealed prominent expression in
the testis cords at 13.5 dpc, in a pattern indicative of Sertoli cell
expression [13] . No sexual dimorphism was observed using in situ
hybridisation or reporter profiling prior to sexual differentiation of
the gonads and at no stage was the level of expression noticeably
higher in XY gonads.
Map3k1-deficient mice are viable and fertile on a mixed
genetic background
We first analysed homozygotes for the Map3k1DKD allele on a
mixed genetic background (see Materials and Methods). All
homozygotes exhibited the eyes open at birth (EOB) phenotype, as
previously described [27,28]. They were otherwise healthy in
appearance and behaviour. We examined fertility in homozygous
males (n = 5) by performing test crosses to wild-type female mice.
All male homozygotes tested generated a copulatory plug and
yielded litters of average size 6.8 (n = 20 litters), examined by
performing openings at mid-gestation. Post-mortem analysis of the
reproductive organs in homozygous males revealed the presence of
motile sperm in the epididymis (n = 7) and no reduction in testis
size (mean=0.11 g STD=0.02 n= 12) when compared to age-
matched controls (mean= 0.09 g STD=0.01 n= 7). Histological
examination of sections revealed numerous seminiferous tubules
containing germ cells. The vas deferens, seminal vesicles and
accessory glands also appeared normal (data not shown). From
these data we conclude that MAP3K1 is not required for testis
determination or testis functioning on a mixed genetic back-
ground.
Analysis of Map3k1DKD/DKD homozygotes on C57BL/6J
reveals normal testis determination but increased
embryonic gonadal length
C57BL/6J (B6) is a genetic background known to be sensitised
to disruptions to testis development [26,38], and therefore we
examined testis development in Map3k1DKD homozygotes after
backcrossing the Map3k1DKD/DKD allele to this inbred strain for
between two to four generations. As previously reported, Map3k1-
deficient mice are mostly non-viable on this background [29].
After intercrossing heterozygous animals, a significant loss of
homozygotes was observed at weaning. Intercrossing backcross-
three heterozygous animals resulted in just 4.3% (6 out of 140)
homozygous animals. Openings at 14.5 dpc revealed homozygous
embryos with a pale appearance due to anaemia and exhibiting
necrosis. Given the frequency of dead and dying homozygous
embryos at 14.5 dpc (45%), we analysed mutant embryos at 14.5
dpc (if still alive) and 13.5 dpc. Anaemic homozygous embryos
Figure 1. Map3k1 is expressed most strongly in the developing gonadal coelomic region as revealed by X-gal staining of the
Map3k1DKD reporter. (A–C) X-gal staining in XX (A) and XY (B) gonads at 11.5 dpc. (C) Transverse section of gonad in (B) at level indicated by dashed
line, revealing expression in the coelomic epithelium and subepithelial mesenchyme. (D–F) Staining of 13.5 dpc XX (D) and XY (E) gonads. (F)
Transverse section of 13.5 dpc testis. CE, coelomic epithelium; WD, Wolffian duct; MD, Mu¨llerian duct.
doi:10.1371/journal.pone.0019572.g001
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were still detected at 13.5 dpc, but in reduced numbers (the
frequency of dead embryos was 10%) and they showed no signs of
tissue necrosis. Chromosomal typing (XY versus XX) revealed no
discordance between chromosomal and gonadal sex in these
embryos. Examination of the embryonic testes at these stages
(n = 26) with markers of distinct cell lineages, including Sertoli cells
(Sox9, AMH), germ cells (Oct4, Stra8), Leydig cells (3-ßHSD) and
ovarian somatic cells (Wnt4) revealed no obvious failure of the
testicular programme of differentiation (Fig. 2A–H), although,
occasionally, small clusters of Stra8-positive cells were observed in
homozygous testes at the caudal pole (see, for example, Fig. 2F).
Stra8 marks meiotic germ cells, normally absent from the testis at
this stage. Curiously, homozygous mutant testes at these stages
consistently appeared longer than controls (see, for example,
Fig. 2E–H). Careful measurement of gonadal length in stage-
matched embryos revealed that mutant testes at 13.5 dpc were on
average 16% longer than wild-type controls (n = 8 stage-matched
pairs, STD =4.73%). No correlative lengthening of Map3k1DKD
embryos was observed.
In order to examine whether gene expression profiles inMap3k1-
deficient gonads were normal at 11.5 dpc, the sex-determining stage
of gonadogenesis, we analysed the expression of Sry (Fig. 2I), Sox9
(Fig. 2J) and Wnt4 (data not shown); no overt differences were
observed between mutants and controls (n= 16 embryonic testes).
Due to the reported increased phosphorylation of p38 in
lymphoblastoid cell lines derived from patients harbouring
mutations of human MAP3K1 [13], we also examined levels of
phospho-p38 (pp38) in control and homozygous mutant gonads at
12.5 dpc (Fig. S1). We observed no significant difference in levels of
pp38 between mutant and control samples.
Figure 2. Marker analysis of Map3k1DKD/DKD XY embryonic gonads reveals minor defects in male development. WMISH and
immunofluorescence were performed at 14.5 dpc (A–D, F & H), 13.5 dpc (E & G) and 11.5 dpc (I–J) using the indicated markers of sexual development.
Respective genotypes are arranged in the following left-to-right order: XY Map3k1+/+; XY Map3k1DKD/DKD; XX Map3k1+/+. (A–D) Sox9 and AMH are
markers of the Sertoli cell lineage and highlight the testis cords. (E) Oct4 marks germ cells in both sexes. Note increased length of the Map3k1DKD/DKD
gonad (centre) and the disorganised cord structure at the caudal pole. (F) Stra8 marks meiotic germ cells, normally only present in embryonic ovaries.
Arrow shows positive cells in XY Map3k1DKD/DKD testis. (G) 3ß–HSD is a Leydig cell marker. (H) Wnt4 is a marker of ovarian somatic cells at this stage. (I)
Sry (a marker of Sertoli cell precursors) expression appears unaltered at the sex-determining stage. (J) Expression of the testis-determining gene Sox9,
at 11.5dpc, appears normal in XY Map3k1DKD/DKD gonads.
doi:10.1371/journal.pone.0019572.g002
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Incompletely penetrant imperforate vagina phenotype in
adult XX Map3k1DKD/DKD homozygotes
We also examined the rare, viable homozygotes that survived to
adulthood. Again, there was no discordance between chromosomal
and phenotypic sex in these animals. Two homozygous mutant
males were shown to be fertile and histological examination of testis
sections revealed no obvious abnormalities. Interestingly, four
homozygous mutant females (out of a total of ten) exhibited
imperforate vagina (Fig. 3). At necropsy, this was shown to be
associated with grossly distended uterine horns. Imperforate vagina
was not observed on the mixed genetic background studied here.
Two females not exhibiting imperforate vagina were also fertility
tested, and between them yielded five litters, with an average of six
pups per litter. Recently, it was reported that mice lacking BCL-2
modifying factor (BMF), a member of the BH3-only group of
proapoptotic proteins, exhibit defects in uterovaginal development,
including an imperforate vagina [39]. BMF is a target for
phosphorylation by JNK, thus MAP3K1 may act upstream of
JNK signaling during uterovaginal tissue morphogenesis.
Investigation of potential genetic interaction between
Map3k1 and Map3k4 in testis determination (on C57BL/
6J)
The observation that absence of MAP3K1 is compatible with
the formation of functional testes on a mixed genetic background
and testis determination and differentiation on B6 suggests the
possibility of functional redundancy, at least during sexual
development. We performed a genetic test to determine whether
MAP3K4 might be able to compensate for the absence of
MAP3K1 during sex determination by generating mice and
embryos lacking both copies of Map3k1 and a single copy of
Map3k4, using a targeted Map3k4 null allele [30]. We have
previously shown that XY mice lacking a single copy of Map3k4
(Map3k4tm1Flv/+) can develop ovotestes or, occasionally, ovaries
when on a highly sensitised genetic background (B6-YAKR) [26],
suggesting that Map3k4 is a dosage-sensitive locus in the
appropriate genetic context. We were unable to generate viable
adults of the genotypeMap3k1DKD/DKD,Map3k4tm1Flv/+ mice on B6,
presumably due to the lethality associated with homozygosity for
Map3k1DKD. However, XY embryos of this genotype examined at
13.5 dpc developed as males with a grossly normal testicular
morphology, although still exhibiting the gonadal lengthening
associated with homozygosity for Map3k1DKD (Fig. 4). Marker
analyses of these testes (n = 8) revealed no abnormalities when
compared to controls (here, Map3k1DKD/DKD homozygous gonads
exhibited a normal ovarian morphology and normal expression of
the markers Sox9, 3ß-HSD, Wnt4 and Oct4 (Fig. 4), consistent with
the fertility of adult females on this background, described above.
We conclude that there is no overt genetic interaction between
Map3k1 and Map3k4 during testis determination in the mouse.
Discussion
Here, we report that absence of MAP3K1 does not disrupt
mouse testis determination on either a mixed genetic background
or on the sensitised B6 background. Whilst it was not possible to
assess testis function on B6 due to non-viability, marker analysis of
XY embryonic gonads on this background indicates that primary
sex determination occurs as normal, with all major testicular
lineages present and no evidence of inappropriate, widespread
ovarian marker expression. Expression of the Map3k1DKD reporter
is consistent with a role in sex determination and male and female
sexual development more broadly. Expression is first observed at
11.0 dpc, and is prominent at 11.5 dpc, the sex-determining stage
of gonad development. Highest levels of expression at this stage
are detected in the coelomic epithelium and sub-epithelial
mesenchymal cells. The significance of this profile is unclear,
Figure 3. XX Map3k1DKD/DKD females on C57BL/6J display
imperforate vagina. (A) Comparison of XX Map3k1+/+ (upper panel)
and XX Map3k1DKD/DKD (lower panel) reproductive tracts reveals grossly
distended and swollen uterine horns (arrows) in the mutant, compared
to wild-type (arrows). Mutants lack a vaginal opening, which is overt in
wild-type individuals (compare arrowheads in inset images). (B)
Dissected reproductive tracts allow the increased size of the mutant
uterine horns to be observed more clearly.
doi:10.1371/journal.pone.0019572.g003
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although the coelomic epithelium is the source of at least a subset
of Sertoli cells [40] and male-enhanced cell proliferation in this
region is one of the first consequences of SRY expression [41].
Reporter signal is diminished by 13.5 dpc and is restricted to the
coelomic epithelium. This observation is in contrast to Map3k1 in
situ hybridisation analysis, which reveals expression in the ovary
and testis cords at 13.5 dpc, consistent with expression in pre-
Sertoli cells [13]. This discrepancy might be explained by the loss
of regulatory elements in the targeted Map3k1DKD allele. Other
aspects of the in situ and reporter expression profiles, including
expression in the developing reproductive tracts, are in agreement,
suggesting that the probe utilised for in situ hybridisation is of good
quality.
One abnormality that was observed in Map3k1DKD homozygous
embryos was an increased length of mutant gonads at 13.5 dpc.
The cellular basis for this phenotype is unclear, however, it might
explain the presence of small clusters of Stra8-positive cells at the
caudal pole of some mutant gonads. The program of testis
development is thought to radiate from initial SRY-dependent
events in the centre of the gonadal primordium. This centre-to-
pole masculinisation is thought to be driven by the secreted
molecule, FGF9 [42]. Any delay in the receipt of this signal by the
gonadal poles can result in the formation of ovarian tissue in this
region, as characterised by ovotestis development, due to
antagonism of the testis-determining pathway by ovarian-deter-
mining genes [43]. The increase in the length of the mutant
gonads reported here might result in occasional delay in the
masculinising signal reaching the poles and subsequent entry of
XY primordial germ cells into meiosis. Notably, successful testis
determination in Map3k1DKD homozygotes is not overtly disrupted
by the further removal of a single copy of Map3k4, a known
dosage-sensitive sex-determining gene in the mouse that also
functions in the MAPK signalling pathway to activate JNK and
p38 [44] [26,45]. Thus, we conclude that MAP3K1 is not required
for testis determination in the mouse, potentially highlighting a
difference between mice and humans with respect to MAP3K1
and its role in sex determination. What might account for this
apparent discrepancy?
Firstly, the established involvement of MAP3K1 in human sex
determination, and MAP3K4 in mouse sex determination,
strongly suggest a conserved role for MAPK signalling in
mammalian sex determination, potentially in the regulation of
the activity of target proteins e.g. transcription factors. However, it
is possible that whilst a conserved signal transduction pathway
exists, these pathways are divergent at the MAP3K level of
functionality: humans employ MAP3K1 (and presumably other
interacting molecules) to regulate this pathway, but there are no
reports of mutations in MAP3K4 causing human DSDs. In
contrast, mice employ MAP3K4 in testis determination and not,
as we demonstrate here, MAP3K1. If this hypothesis of a
conserved role for MAPK signalling is correct, there must be
convergence of the pathway in mice and humans at the level of
MAP2K, MAPK or target protein functionality and this can be
tested by the identification of sex reversing MAP2K or MAPK
mutations in both mice and humans, or mutations in MAPK
target genes. A systematic genetic analysis is complicated by the
potential number of genes involved at this level of the MAPK
pathway. MAP3K4 can activate the MAPKs p38 and JNK via the
phosphorylation of the MAP2Ks MKK3/MKK6 and MKK4/
MKK7, respectively [44,45]. MAP3K1 can phosphorylate MKK4
to activate JNK and MKK1 to activate ERK1/2 [15,46]. Thus,
several MAP2Ks may play a role. Moreover, there are three
mammalian genes encoding JNK, and four encoding p38 isoforms
[47].
A second way of explaining the apparent discrepancy between
the roles of MAP3K genes in mice and humans involves the nature
of the human mutations themselves. Functional studies in mice,
such as that described here, invariably involve loss-of-function
alleles generated by gene targeting. However, the spectrum of
alleles contributing to human genetic disease is much greater, and
Figure 4. Map3k1 does not function redundantly with Map3k4 during sex determination. WMISH was performed at 13.5 dpc using the
following probes: (A) Sox9, (B) 3ß-HSD, (C) Wnt4, (D) Oct4. Respective genotypes are arranged in the following left-to-right order: XY Map3k1DKD/DKD,
Map3k4+/+; XY Map3k1DKD/DKD, Map3k4tm1Flv/+; XX Map3k1DKD/DKD, Map3k1DKD/DKD, Map3k4+/+. Following marker analysis, the expression patterns
observed using XY compound mutant gonads were indistinguishable from those of controls.
doi:10.1371/journal.pone.0019572.g004
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this may underlie the difference between humans and mice
harbouring MAP3K1 mutations. It is notable that none of the
MAP3K1 mutations reported to disrupt human testis development
are truncating i.e. none encode early termination codons in the
MAP3K1 polypeptide [13]. This suggests that these mutations do
not generate null alleles, possibly reflecting a loss of viability in
humans exhibiting widespread absence of MAP3K1 function, as in
mice on the B6 background. Assays in lymphoblastoid cell lines
revealed increased phosphorylation of the MAPKs, p38 and ERK.
How increased activity of MAPKs could disrupt testis determina-
tion, in the absence of known MAPK target proteins that function
in sex determination, is, however, unclear. Disruption to one or
more protein interactions of MAP3K1, which are numerous [48],
may contribute to the sex-reversal phenotype. It is also worth
noting that putative MAP3K1 gain-of-function during XY female
development might be interpreted as implying a positive role for
MAP3K1 in ovary development itself. However, on C57BL/6J,
XX Map3k1DKD/DKD homozygous adult females (n = 2) were fertile
and homozygous XX embryos exhibited no overt abnormalities of
ovary development. Thus, there appears to be no requirement for
MAP3K1 in ovary determination in mice.
Finally, the possibility of unconventional roles for MAP3K1 in
sex determination cannot be excluded. MAP3K1 differs from
MAP3K2, MAP3K3 and MAP3K4 in exhibiting lower levels of
conservation in its kinase domain and in being a strong stimulator
of apoptosis [49]. MAP3K1 is a 196-kDa protein that encodes a
protease cleavage sequence for caspase-3-like proteases and UV
irradiation and DNA-damaging chemicals activate MAP3K1
kinase function and induce its proteolytic cleavage [50]. These
data suggest that MAP3K1 is an integral component of the
apoptotic response. We cannot exclude disruption to this or other
unconventional functions of MAP3K1 as causes of human sex
reversal. Further careful experimentation will be required to
appropriately address these complex issues.
Supporting Information
Figure S1 Levels of phosphorylated p38 (pp38) are not
altered in 12.5 dpc gonads of Map3k1DKD/DKD embryos.
(A) Western blot analysis of protein samples from sub-dissected
12.5 dpc embryonic gonads using the antibodies indicated. ß-actin
detection was used as a loading control. pp38 and p38 levels
appear very similar in homozygous mutants (homo) and controls.
(B) Graphical representation of the average normalised levels of
pp38 and p38 (derived from two independent pairs of samples
(four gonads)). Two-tailed t-tests confirm that the levels are not
significantly different between samples (pp38, p = 0.393; p38,
p = 0.686).
(TIFF)
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